Objective: Although substance use disorder (SUD) among older adults is increasing, little has been documented about recent increases in admissions to treatment facilities and associated patient and population characteristics.
Methods: We used nationwide data from the Treatment Episode Data Set: Admissions to examine annual admissions to SUD treatment facilities between 2000–2001 and 2016–2017 among adults 55 years and older compared to those aged 21 to 54. Analyses addressed the impact on admission rates of increases in the general older adult population and in sociodemographic and clinical characteristics of those admitted using bivariate and multivariate logistic regressions.
Results: From 2000 to 2017, the number of older adults admitted to SUD treatment facilities increased by 203.7% as compared to 13.0% among younger adults. Admissions per 1,000 adults in the general population moderated these differences to 98.4% vs 7.2%. Older adults showed greater increases relative to younger adults in proportions admitted for cocaine/crack (odds ratio [OR], 5.35; 95% confidence interval [CI], 5.20–5.51) and cannabis (OR, 1.81; 95% CI, 1.72–1.91) use and a relative decrease in admission for opiates (OR, 0.76; 95% CI, 0.73–0.80) and alcohol (OR, 0.79; 95% CI, 0.78–0.80) along with changes in some demographics. Multivariate analysis showed that the OR for admission among older adults, as compared to younger adults, was 1.73 (95% CI, 1.65–1.80) in 2016–2017 compared to 2000–2001, adjusting for other factors.
Conclusions: The number and proportion of older adults admitted to SUD treatment facilities increased substantially from 2000 to 2017 and were associated with changes in both population numbers and patient characteristics, especially a relative increase among older adults in cocaine/crack and cannabis use and a relative decrease for use of alcohol and opioids.
Continue Reading...
Members enjoy unlimited free PDF downloads as part of their subscription! Subscribe today for instant access to this article and our entire library in your preferred format. Alternatively, you can purchase the PDF of this article individually.
Substance Abuse and Mental Health Services Administration Office of Applied Studies. The TEDS Report: Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998 and 2008. Substance Abuse and Mental Health Services Administration; 2010.
Substance Abuse and Mental Health Services Administration. Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Substance Abuse and Mental Health Services Administration; 2013.
Chhatre S, Cook R, Mallik E, et al. Trends in substance use admissions among older adults. BMC Health Serv Res. 2017;17(1):584. PubMedCrossRef
Gfroerer J, Penne M, Pemberton M, et al. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2003;69(2):127–135. PubMedCrossRef
Han B, Gfroerer JC, Colliver JD, et al. Substance use disorder among older adults in the United States in 2020. Addiction. 2009;104(1):88–96. PubMedCrossRef
Widlitz M, Marin DB. Substance abuse in older adults: an overview. Geriatrics. 2002;57(12):29–34, quiz 37. PubMed
Arndt S, Clayton R, Schultz SK. Trends in substance abuse treatment 1998–2008: increasing older adult first-time admissions for illicit drugs. Am J Geriatr Psychiatry. 2011;19(8):704–711. PubMedCrossRef
Rao R, Roche A. Substance misuse in older people. BMJ. 2017;358:j3885. PubMedCrossRef
National Academies of Sciences Engineering and Medicine (US). Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. In: Bonnie RJ, Ford MA, Phillips J, eds. Pain Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of Prescription Opioid Use. The National Academies Press; 2017.
Hall W, Lynskey M. Assessing the public health impacts of legalizing recreational cannabis use: the US experience. World Psychiatry. 2020;19(2):179–186. PubMedCrossRef
Airagnes G, Pelissolo A, Lavallée M, et al. Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep. 2016;18(10):89. PubMedCrossRef
Buck JA. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff (Millwood). 2011;30(8):1402–1410. PubMedCrossRef
Busch SH, Meara E, Huskamp HA, et al. Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. Psychiatr Serv. 2013;64(6):520–526. PubMedCrossRef
Ferguson CJ. An effect size primer: a guide for clinicians and researchers. Prof Psychol Res Pr. 2009;40(5):532–538. CrossRef
Liang KY, Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73(1):13–22. CrossRef
Grant BF, Goldstein RB, Saha TD, et al. Epidemiology of DSM-5 alcohol use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry. 2015;72(8):757–766. PubMedCrossRef
Hasin DS, Saha TD, Kerridge BT, et al. Prevalence of marijuana use disorders in the United States between 2001–2002 and 2012–2013. JAMA Psychiatry. 2015;72(12):1235–1242. PubMedCrossRef
Palamar JJ, Davies S, Ompad DC, et al. Powder cocaine and crack use in the United States: an examination of risk for arrest and socioeconomic disparities in use. Drug Alcohol Depend. 2015;149:108–116. PubMedCrossRef
Jones E, Huey SJ, Rubenson M. Cultural competence in therapy with African Americans. In: Frisby CL, O’Donohue WT, eds. Cultural Competence in Applied Psychology. Springer; 2018:557–573.
Paul NB, Lopez LA, Strong MN, et al. Cultural considerations in the behavioral assessment and treatment of substance-related disorders. In: Benuto LT, Gonzalez FR, Singer J, eds. Handbook of Cultural Factors in Behavioral Health: A Guide for the Helping Professional. Springer; 2020.
Huhn AS, Strain EC, Tompkins DA, et al. A hidden aspect of the US opioid crisis: rise in first-time treatment admissions for older adults with opioid use disorder. Drug Alcohol Depend. 2018;193:142–147. PubMedCrossRef
Han BH, Sherman SE, Palamar JJ. Prescription opioid misuse among middle-aged and older adults in the United States, 2015-2016. Prev Med. 2019;121:94–98. PubMedCrossRef
Han BH, Palamar JJ. Trends in cannabis use among older adults in the United States, 2015–2018. JAMA Intern Med. 2020;180(4):609–611. PubMedCrossRef
Caulkins JP, Kilmer B, Reuter PH, et al. Cocaine’s fall and marijuana’s rise: questions and insights based on new estimates of consumption and expenditures in US drug markets. Addiction. 2015;110(5):728–736. PubMedCrossRef
Centers for Disease Control and Prevention. Underlying Cause of Death 1999–2018, CDC WONDER online database. https://wonder.cdc.gov/ucd-icd10.html. 2020.
Han B, Cotto J, Etz K, et al. Methamphetamine overdose deaths in the US by sex and race and ethnicity. JAMA Psychiatry. 2021;78(5):564–567. PubMedCrossRef
Lehmann SW, Fingerhood M. Substance-use disorders in later life. N Engl J Med. 2018;379(24):2351–2360. PubMedCrossRef
2019 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2019 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019;67(4):674–694. PubMedCrossRef
Kuerbis A, Sacco P, Blazer DG, et al. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629–654. PubMedCrossRef
Manhapra A, Stefanovics EA, Rhee TG, et al. Who uses veterans mental health services? a national observational study of male veteran and nonveteran mental health service users. J Nerv Ment Dis. 2021;209(10):702–709. PubMedCrossRef